Compound information
- Natural Products
- ZC709462
- Molecular Formula
- C16H22N2O6S
- Molecular Weight
- 370.119857424 g/mol
- Structure
-
- IUPAC Name
- 3-(4-tert-butoxycarbonylpiperazin-1-yl)sulfonylbenzoic acid
- InChI
- InChI=1S/C16H22N2O6S/c1-16(2,3)24-15(21)17-7-9-18(10-8-17)25(22,23)13-6-4-5-12(11-13)14(19)20/h4-6,11H,7-10H2,1-3H3,(H,19,20)
- InChI Key
- NEONUMCAWBLQLU-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCN(S(=O)(=O)c2cccc(C(=O)O)c2)CC1
- Source
- ZINC000013461356
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 104.22 Å2 | LogP | 2.234 |
LogS | -3.126 | LogD | 1.397 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.011 | Pgp substrate | 0.053 |
HIA | 0.958 | F20 % | 0.59 |
F30 % | 0.658 | Caco-2 | -5.002 |
MDCK | -5.298 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.116 | PPB | 86.693 |
VD | 0.661 | Fu | 0.522 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.007 | CYP1A2 substrate | 0.39 |
CYP2A6 substrate | 0.496 | CYP2B6 substrate | 0.642 |
CYP2C19 inhibitor | 0.072 | CYP2C19 substrate | 0.688 |
CYP2C8 substrate | 0.573 | CYP2C9 inhibitor | 0.031 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.02 |
CYP2D6 substrate | 0.424 | CYP2E1 substrate | 0.849 |
CYP3A4 inhibitor | 0.006 | CYP3A4 substrate | 0.989 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.85 | CL | 4.701 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.067 | Hepatotoxicity | 0.715 |
Mutagenicity | 0.019 | Rat Oral Acute Toxicity | 0.025 |
FDAMDD | 0.018 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.053 | Eye Corrosion | 0.001 |
Eye Irritation | 0.063 | Respiratory Toxicity | 0.01 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.824 | IGC50 | 2.122 |
LC50FM | 1.903 | LC50DM | 2.441 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.315 | NR-AR-LBD | 0.297 |
NR-AhR | 0.024 | NR-Aromatase | 0.03 |
NR-ER | 0.233 | NR-ER-LBD | 0.403 |
NR-PPAR-gamma | 0.165 | SR-ARE | 0.2 |
SR-ATAD5 | 0.341 | SR-HSE | 0.057 |
SR-MMP | 0.013 | SR-p53 | 0.041 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.